Ciliary Ion Channels in Polycystic Kidney Disease

Polycystic kidney disease (PKD) is the most common hereditary disorder that disrupts renal function and frequently progresses to end-stage renal disease. Recent advances have elucidated the critical role of primary cilia and ciliary ion channels, including transient receptor potential (TRP) channels...

Full description

Saved in:
Bibliographic Details
Main Authors: Lubna A. Alshriem, Raghad Buqaileh, Qasim Alorjani, Wissam AbouAlaiwi
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/6/459
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850090320892526592
author Lubna A. Alshriem
Raghad Buqaileh
Qasim Alorjani
Wissam AbouAlaiwi
author_facet Lubna A. Alshriem
Raghad Buqaileh
Qasim Alorjani
Wissam AbouAlaiwi
author_sort Lubna A. Alshriem
collection DOAJ
description Polycystic kidney disease (PKD) is the most common hereditary disorder that disrupts renal function and frequently progresses to end-stage renal disease. Recent advances have elucidated the critical role of primary cilia and ciliary ion channels, including transient receptor potential (TRP) channels, cystic fibrosis transmembrane conductance regulator (CFTR), and polycystin channels, in the pathogenesis of PKD. While some channels primarily function as chloride conductance channels (e.g., CFTR), others primarily regulate calcium (Ca<sup>+2</sup>) homeostasis. These ion channels are essential for cellular signaling and maintaining the normal kidney architecture. Dysregulation of these pathways due to genetic mutations in <i>PKD1</i> and <i>PKD2</i> leads to disrupted Ca<sup>+2</sup> and cAMP signaling, aberrant fluid secretion, and uncontrolled cellular proliferation, resulting in tubular cystogenesis. Understanding the molecular mechanisms underlying these dysfunctions has opened the door for innovative therapeutic strategies, including TRPV4 activators, CFTR inhibitors, and calcimimetics, to mitigate cyst growth and preserve renal function. This review summarizes the current knowledge on the roles of ciliary ion channels in PKD pathophysiology, highlights therapeutic interventions targeting these channels, and identifies future research directions for improving patient outcomes.
format Article
id doaj-art-8af110669adc4b2e93c252000e77b6e7
institution DOAJ
issn 2073-4409
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-8af110669adc4b2e93c252000e77b6e72025-08-20T02:42:35ZengMDPI AGCells2073-44092025-03-0114645910.3390/cells14060459Ciliary Ion Channels in Polycystic Kidney DiseaseLubna A. Alshriem0Raghad Buqaileh1Qasim Alorjani2Wissam AbouAlaiwi3Department of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USADepartment of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USADepartment of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USADepartment of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USAPolycystic kidney disease (PKD) is the most common hereditary disorder that disrupts renal function and frequently progresses to end-stage renal disease. Recent advances have elucidated the critical role of primary cilia and ciliary ion channels, including transient receptor potential (TRP) channels, cystic fibrosis transmembrane conductance regulator (CFTR), and polycystin channels, in the pathogenesis of PKD. While some channels primarily function as chloride conductance channels (e.g., CFTR), others primarily regulate calcium (Ca<sup>+2</sup>) homeostasis. These ion channels are essential for cellular signaling and maintaining the normal kidney architecture. Dysregulation of these pathways due to genetic mutations in <i>PKD1</i> and <i>PKD2</i> leads to disrupted Ca<sup>+2</sup> and cAMP signaling, aberrant fluid secretion, and uncontrolled cellular proliferation, resulting in tubular cystogenesis. Understanding the molecular mechanisms underlying these dysfunctions has opened the door for innovative therapeutic strategies, including TRPV4 activators, CFTR inhibitors, and calcimimetics, to mitigate cyst growth and preserve renal function. This review summarizes the current knowledge on the roles of ciliary ion channels in PKD pathophysiology, highlights therapeutic interventions targeting these channels, and identifies future research directions for improving patient outcomes.https://www.mdpi.com/2073-4409/14/6/459polycystic kidney diseaseprimary ciliaion channelspolycystinCa<sup>+2</sup>TRPV4
spellingShingle Lubna A. Alshriem
Raghad Buqaileh
Qasim Alorjani
Wissam AbouAlaiwi
Ciliary Ion Channels in Polycystic Kidney Disease
Cells
polycystic kidney disease
primary cilia
ion channels
polycystin
Ca<sup>+2</sup>
TRPV4
title Ciliary Ion Channels in Polycystic Kidney Disease
title_full Ciliary Ion Channels in Polycystic Kidney Disease
title_fullStr Ciliary Ion Channels in Polycystic Kidney Disease
title_full_unstemmed Ciliary Ion Channels in Polycystic Kidney Disease
title_short Ciliary Ion Channels in Polycystic Kidney Disease
title_sort ciliary ion channels in polycystic kidney disease
topic polycystic kidney disease
primary cilia
ion channels
polycystin
Ca<sup>+2</sup>
TRPV4
url https://www.mdpi.com/2073-4409/14/6/459
work_keys_str_mv AT lubnaaalshriem ciliaryionchannelsinpolycystickidneydisease
AT raghadbuqaileh ciliaryionchannelsinpolycystickidneydisease
AT qasimalorjani ciliaryionchannelsinpolycystickidneydisease
AT wissamaboualaiwi ciliaryionchannelsinpolycystickidneydisease